Lyra Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LYRA and other ETFs, options, and stocks.About LYRA
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases.
CEOMaria Palasis
CEOMaria Palasis
Employees30
Employees30
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded2005
Founded2005
Employees30
Employees30
LYRA Key Statistics
Market cap6.39M
Market cap6.39M
Price-Earnings ratio-0.08
Price-Earnings ratio-0.08
Dividend yield—
Dividend yield—
Average volume12.85M
Average volume12.85M
High today$0.1021
High today$0.1021
Low today$0.087
Low today$0.087
Open price$0.0964
Open price$0.0964
Volume3.05M
Volume3.05M
52 Week high$0.398
52 Week high$0.398
52 Week low$0.082
52 Week low$0.082
People also own
Based on the portfolios of people who own LYRA. This list is generated using Robinhood data, and it’s not a recommendation.